Skip to content

Flow-Pac LDH Reagent Set

by Amresco, Inc.

510(k) K823721

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK823721 Date9 Jan 1983ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
CFJ
Device Class
Class II
Regulation
21 CFR Part 862.1440
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Flow-Pac LDH Reagent Set is a diagnostic reagent system for measuring lactate dehydrogenase (LDH) activity, classified under the device type Nad Reduction/Nadh Oxidation, Lactate Dehydrogenase. LDH assays are used to evaluate cellular damage, particularly in clinical chemistry settings, by quantifying the enzyme’s role in metabolic pathways.

This reagent set is supplied as a single-use diagnostic tool, intended for use in automated clinical chemistry analyzers. It requires no sterilization beyond manufacturer-provided packaging and is regulated under FDA 510(k) clearance (K823721) with a product code of CFJ. Storage conditions and compatibility with specific analyzers are detailed in the accompanying instructions, though no MRI safety or reusable components are indicated.

Other devices from Amresco, Inc.

See all devices from Amresco, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical setting or specialty is the Flow-Pac LDH Reagent Set primarily used in, and why is it relevant for that setting?

    The Flow-Pac LDH Reagent Set is designed for use in clinical chemistry settings, where it helps evaluate cellular damage by measuring lactate dehydrogenase (LDH) activity. LDH assays are critical for diagnosing conditions like tissue injury, hemolysis, or certain metabolic disorders, making it particularly relevant for labs focused on biochemical analysis and patient monitoring.

  • Is the Flow-Pac LDH Reagent Set intended for single-use or repeated use, and what does that mean for workflow efficiency?

    The Flow-Pac LDH Reagent Set is explicitly labeled as a single-use diagnostic tool, meaning each set is designed for one-time use in automated clinical chemistry analyzers. This ensures consistency in test results and reduces the risk of contamination, though it may require clinicians to plan reagent usage carefully to maintain workflow efficiency.

  • How should the Flow-Pac LDH Reagent Set be stored, and are there any special handling instructions beyond standard lab practices?

    Storage conditions for the Flow-Pac LDH Reagent Set are detailed in the manufacturer’s instructions, though the data does not specify exact requirements beyond what is provided in the packaging. Since it is a single-use diagnostic reagent, it should be stored in a way that preserves its integrity—typically at room temperature or refrigerated, away from direct light and moisture—until use. Always follow the included instructions to avoid compromising reagent stability.

  • What type of analyzers is the Flow-Pac LDH Reagent Set compatible with, and how does this affect its usability in different lab environments?

    The Flow-Pac LDH Reagent Set is intended for use in automated clinical chemistry analyzers, though the exact compatible models are not listed in the provided data. Compatibility is likely specified in the accompanying instructions, so labs should verify their analyzer’s compatibility before use. This ensures accurate LDH measurements and seamless integration into existing workflows.

  • What regulatory pathway was followed for the FDA clearance of the Flow-Pac LDH Reagent Set, and what does this mean for its safety and performance standards?

    The Flow-Pac LDH Reagent Set received FDA 510(k) clearance (K823721) under the Traditional pathway, with a classification of Substantially Equivalent (SESE) to a predicate device. This means its safety and performance were determined to be comparable to an existing, legally marketed device, ensuring it meets FDA standards for clinical chemistry reagents. The clearance also falls under product code CFJ, which pertains to diagnostic reagents.